Lowering the increased intracellular pH of human-induced pluripotent stem cell-derived endothelial cells induces formation of mature Weibel-Palade bodies.


Journal

Stem cells translational medicine
ISSN: 2157-6580
Titre abrégé: Stem Cells Transl Med
Pays: England
ID NLM: 101578022

Informations de publication

Date de publication:
07 2020
Historique:
received: 18 11 2019
accepted: 17 02 2020
pubmed: 13 3 2020
medline: 22 7 2021
entrez: 13 3 2020
Statut: ppublish

Résumé

Differentiation of human-induced pluripotent stem cells (hiPSCs) into vascular endothelium is of great importance to tissue engineering, disease modeling, and use in regenerative medicine. Although differentiation of hiPSCs into endothelial-like cells (hiPSC-derived endothelial cells [hiPSC-ECs]) has been demonstrated before, controversy exists as to what extent these cells faithfully reflect mature endothelium. To address this issue, we investigate hiPSC-ECs maturation by their ability to express von Willebrand factor (VWF) and formation of Weibel-Palade bodies (WPBs). Using multiple hiPSCs lines, hiPSC-ECs failed to form proper VWF and WPBs, essential for angiogenesis, primary and secondary homeostasis. Lowering the increased intracellular pH (pHi) of hiPSC-ECs with acetic acid did result in the formation of elongated WPBs. Nuclear magnetic resonance data showed that the higher pHi in hiPSC-ECs occurred in association with decreased intracellular lactate concentrations. This was explained by decreased glycolytic flux toward pyruvate and lactate in hiPSC-ECs. In addition, decreased expression of monocarboxylate transporter member 1, a member of the solute carrier family (SLC16A1), which regulates lactate and H+ uptake, contributed to the high pHi of hiPSC-EC. Mechanistically, pro-VWF dimers require the lower pH environment of the trans-Golgi network for maturation and tubulation. These data show that while hiPSC-ECs may share many features with mature EC, they are characterized by metabolic immaturity hampering proper EC function.

Identifiants

pubmed: 32163224
doi: 10.1002/sctm.19-0392
pmc: PMC7308639
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

758-772

Informations de copyright

© 2020 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.

Références

Acta Physiol (Oxf). 2017 Feb;219(2):382-408
pubmed: 27246807
Cell. 2011 Sep 16;146(6):873-87
pubmed: 21925313
Dev Cell. 2006 Feb;10(2):223-32
pubmed: 16459301
J Thromb Haemost. 2017 Jan;15(1):13-20
pubmed: 27778439
Cancer Res. 2003 Jun 15;63(12):3403-12
pubmed: 12810677
Cell. 1991 Jan 25;64(2):403-13
pubmed: 1988154
Mol Cell Biochem. 1998 Mar;180(1-2):85-93
pubmed: 9546634
Nat Rev Mol Cell Biol. 2010 Jan;11(1):50-61
pubmed: 19997129
Arterioscler Thromb Vasc Biol. 2020 Feb;40(2):350-364
pubmed: 31826652
Brain Res. 2011 Feb 28;1376:10-22
pubmed: 21192921
Annu Rev Biochem. 1998;67:395-424
pubmed: 9759493
J Mol Cell Cardiol. 1990 Dec;22(12):1393-404
pubmed: 2089157
Cell. 2013 Aug 1;154(3):651-63
pubmed: 23911327
J Thromb Haemost. 2013 Jun;11 Suppl 1:192-201
pubmed: 23809123
Cell Stem Cell. 2017 Oct 5;21(4):502-516.e9
pubmed: 28965765
EMBO J. 2011 Aug 19;30(19):4098-111
pubmed: 21857647
Science. 1997 Jul 4;277(5322):55-60
pubmed: 9204896
Stem Cell Reports. 2018 May 8;10(5):1642-1656
pubmed: 29657098
Curr Biol. 2012 May 8;22(9):R330-9
pubmed: 22575475
Stem Cell Reports. 2018 Mar 13;10(3):751-765
pubmed: 29503086
J Thromb Haemost. 2018 Jul;16(7):1357-1368
pubmed: 29734512
Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):137-45
pubmed: 25359860
EMBO J. 2002 Aug 15;21(16):4307-16
pubmed: 12169633
PLoS One. 2012;7(3):e33418
pubmed: 22428047
Stem Cells Transl Med. 2017 Feb;6(2):405-418
pubmed: 28191776
Cell Stem Cell. 2013 Aug 1;13(2):246-54
pubmed: 23910086
Biochim Biophys Acta. 1990 May 7;1031(2):225-46
pubmed: 2160275
Nature. 2019 Jan;565(7740):505-510
pubmed: 30651639
Am J Transl Res. 2013;5(1):21-35
pubmed: 23390563
Pharmacol Ther. 2017 Mar;171:30-42
pubmed: 27916653
Physiol Rev. 2018 Jan 1;98(1):3-58
pubmed: 29167330
Cell Stem Cell. 2017 Apr 6;20(4):490-504.e5
pubmed: 28017794
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Angew Chem Int Ed Engl. 2017 Mar 20;56(13):3531-3535
pubmed: 28220994
Blood. 2006 Jun 1;107(11):4354-63
pubmed: 16455954
Circulation. 2007 Mar 13;115(10):1285-95
pubmed: 17353456
EMBO J. 2011 Oct 05;30(19):3880-1
pubmed: 21975375
Arterioscler Thromb Vasc Biol. 2006 May;26(5):1002-7
pubmed: 16469951
Nat Protoc. 2014;9(6):1514-31
pubmed: 24874816
Anal Chim Acta. 2017 Aug 8;980:1-24
pubmed: 28622799
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6803-8
pubmed: 9618493
Blood. 2010 Dec 16;116(25):5762-72
pubmed: 20884805
Dev Cell. 2014 May 12;29(3):292-304
pubmed: 24794632
Blood. 2015 Mar 26;125(13):2019-28
pubmed: 25712991
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
J Cell Biol. 1986 Apr;102(4):1320-4
pubmed: 3082891
J Biol Chem. 2006 Jun 9;281(23):16108-16
pubmed: 16601116
Nature. 2017 Nov 2;551(7678):115-118
pubmed: 29045397
J Thromb Haemost. 2020 Jan;18(1):243-254
pubmed: 31519030
J Biol Chem. 2011 Jul 8;286(27):24180-8
pubmed: 21596755
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):e72-9
pubmed: 21836062
Physiology (Bethesda). 2017 Nov;32(6):453-463
pubmed: 29021365
Stem Cell Reports. 2019 Nov 12;13(5):803-816
pubmed: 31680061
Blood. 2011 May 12;117(19):5033-43
pubmed: 21266719
Stem Cells Transl Med. 2020 Jul;9(7):758-772
pubmed: 32163224
Stem Cells Dev. 2011 Oct;20(10):1701-10
pubmed: 21235328
IUBMB Life. 2012 Feb;64(2):109-19
pubmed: 22162139
Nature. 2016 Jan 21;529(7586):316-25
pubmed: 26791722
Front Physiol. 2012 Apr 02;3:76
pubmed: 22485092
EMBO J. 1993 Feb;12(2):749-58
pubmed: 8440262
Blood. 2014 Aug 28;124(9):1412-25
pubmed: 24928861
Stem Cell Reports. 2013 Jul 25;1(2):105-13
pubmed: 24052946
Traffic. 2006 Jun;7(6):647-62
pubmed: 16683915
N Engl J Med. 2016 Nov 24;375(21):2067-2080
pubmed: 27959741
J Crit Care. 2012 Apr;27(2):108-18
pubmed: 21798701
J Cell Sci. 2008 Jan 1;121(Pt 1):19-27
pubmed: 18096688
Stem Cell Reports. 2019 Mar 5;12(3):597-610
pubmed: 30799273

Auteurs

Gesa L Tiemeier (GL)

The Einthoven Laboratory for Vascular and Regenerative Medicine, Division of Nephrology, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Rozemarijn de Koning (R)

The Einthoven Laboratory for Vascular and Regenerative Medicine, Division of Nephrology, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Gangqi Wang (G)

The Einthoven Laboratory for Vascular and Regenerative Medicine, Division of Nephrology, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Sarantos Kostidis (S)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.

Rosalie G J Rietjens (RGJ)

The Einthoven Laboratory for Vascular and Regenerative Medicine, Division of Nephrology, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Wendy M P J Sol (WMPJ)

The Einthoven Laboratory for Vascular and Regenerative Medicine, Division of Nephrology, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Sébastien J Dumas (SJ)

Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium.
Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, Leuven, Belgium.

Martin Giera (M)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.

Cathelijne W van den Berg (CW)

The Einthoven Laboratory for Vascular and Regenerative Medicine, Division of Nephrology, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Jeroen C J Eikenboom (JCJ)

The Einthoven Laboratory for Experimental Vascular Medicine, Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.

Bernard M van den Berg (BM)

The Einthoven Laboratory for Vascular and Regenerative Medicine, Division of Nephrology, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Peter Carmeliet (P)

Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium.
Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, Leuven, Belgium.

Ton J Rabelink (TJ)

The Einthoven Laboratory for Vascular and Regenerative Medicine, Division of Nephrology, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH